Alborz Darou pharmaceutical company - Company Review
SummaryAlborz Darou pharmaceutical company - Company Review
Summary
Alborz Darou Pharmaceutical Company (Alborz Darou) is a drug manufacturing and distributing company that markets pharmaceutical finished dosage forms. The company's products include adi gel tablets s, poly-powered tablet, arsvdaksy colic acid capsules,vnvla capsules, piracetam tablets, fluvoxamine tablets, tramadol tablets, verapamil tablets, painter xl, parkin tablet pc and acetaminophen tablets. It offers dry products, sterile and liquid products. Alborz Darou provides products in the form of tablets, capsules, ampoules, prefilled syringes, suspensions and soft liquids. The company markets its products thought its distribution network and partners throughout the world. Alborz Darou is headquartered in Tehran, Iran.
This comprehensive company report of Alborz Darou pharmaceutical company provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.